A recent clinical study has been released, evaluating the ocular and peri-ocular tolerance and the efficacy of TOLERIANE DERMALLERGO EYES.
The open study La Roche-Posay conducted, included male and female subjects of the caucasian type, over the age 18 who show palpebral eczema or sensitive skin, especially around the eyes.
Already 10 min after application, TOLERIANE DERMALLERGO EYES shows an average reduction of 26% on the intensity of the below listed functional signs. After 14 days of application, the average decrease of proportion is 41%. Finally, after 28 days of use there is a general reduction of 63% for the investigated functional signs.